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a b s t r a c t 
Hematopoietic stem cells (HSCs) have proven their clinical relevance in stem cell transplantation to cure 
patients with hematological disorders. Key to their regenerative potential is their natural microenviron- 
ment – their niche – in the bone marrow (BM). Developments in the field of biomaterials enable the 
recreation of such environments with increasing preciseness in the laboratory. Such artificial niches help 
to gain a fundamental understanding of the biophysical and biochemical processes underlying the in- 
teraction of HSCs with the materials in their environment and the disturbance of this interplay during 
diseases affecting the BM. Artificial niches also have the potential to multiply HSCs in vitro , to enable 
the targeted differentiation of HSCs into mature blood cells or to serve as drug-testing platforms. In this 
review, we will introduce the importance of artificial niches followed by the biology and biophysics of 
the natural archetype. We will outline how 2D biomaterials can be used to dissect the complexity of 
the natural niche into individual parameters for fundamental research and how 3D systems evolved from 
them. We will present commonly used biomaterials for HSC research and their applications. Finally, we 
will highlight two areas in the field of HSC research, which just started to unlock the possibilities pro- 
vided by novel biomaterials , in vitro blood production and studying the pathophysiology of the niche in 
vitro . With these contents, the review aims to give a broad overview of the different biomaterials applied 
for HSC research and to discuss their potentials, challenges and future directions in the field. 
Statement of significance 
Hematopoietic stem cells (HSCs) are multipotent cells responsible for maintaining the turnover of all 
blood cells. They are routinely applied to treat patients with hematological diseases. This high clinical 
relevance explains the necessity of multiplication or differentiation of HSCs in the laboratory, which is 
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Blood cells need to be constantly produced, as their loss due 
o immune response, injury or an intrinsically limited lifespan de- 
ands their dynamic replenishment. In adult humans, this process 
ypically takes place in the bone marrow (BM) and is performed 
y hematopoietic stem cells (HSCs) [1] . HSCs are defined by their 
bility to self-renew as well as giving rise to lineage-determined 
aughter cells, that are able to differentiate into all cell types of 
he hematopoietic system [2] . Maintenance of these remarkable 
eatures of HSCs can only be achieved within specialized microen- 
ironments, called the HSC niches, located in the BM of trabecular 
ones [ 1 , 26 ]. Hematopoiesis, production of blood cells from HSCs, 
s a highly regulated and hierarchical process. The multitude of fac- 
ors involved in the physiology of the HSC niche makes the pro- 
uction of biomaterial-based artificial niches challenging. However, 
he potential of such platforms has stirred the interest of many re- 
earch groups, as they could be used to study the mechanisms in- 
olved in the maintenance of the healthy niche and the pathophys- 
iology of the diseased BM [ 5 , 6 ]. Most importantly, biomimetic ma- 
terials can be utilized for efficient expansion of HSCs ex vivo with- 
out the loss of stemness for which there is a dire need in the cur-
rent clinical landscape due to the limited pool of available donors 
[ 7 , 8 ]. In addition, targeted HSC differentiation for in vitro blood 
production can be enhanced by biomaterial-based artificial niches 
[9–11] . Attempts to recreate the disordered niche offer insight into 
the resulting malignancies and provide drug-testing platforms to 
counter them [12–15] ( Fig. 1 ). Usually, such tasks are carried out 
using animal models, which are not fully comparable to the human 
system. More importantly, they have to be implemented and ac- 
cepted under ethical standpoints into the 3Rs principle to Reduce, 
Refine and Replace animal models [16] . With this review, we aim 
to highlight recent developments in the field of biomaterials for 
HSC culture. Starting with the description of the biology and bio- 
physics of the natural archetype, we will discuss 2D biomaterial- 
based approaches to dissect the niche complexity for fundamen- 
tal studies. Then we move on to the diverse 3D culture systems 
used for mimicking the natural niche as well as the importance of 2 ral microenvironment – the so called niche. Biomaterials offer the possi- 
us overcome this hurdle. The review introduces the HSC niche in the bone 
ty of biomaterials in creating artificial niches. It outlines how 2D systems 
latforms, which opened the gateway to applications such as, expansion of 
 blood production, studying niche pathologies and drug testing. 
1 The Authors. Published by Elsevier Ltd on behalf of Acta Materialia Inc. 
icle under the CC BY license ( http://creativecommons.org/licenses/by/4.0/ ) 
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iomaterials for in vitro blood production. Finally, we discuss the 
ttempts made in replicating the niche under certain pathological 
ircumstances and the importance of such systems to further un- 
erstand and intervene in the resulting diseases. 
. Biology of the HSC niche 
First put forth by Schofield et al. in 1978 [17] , the niche concept 
as grown from a mere hypothesis into a widespread model of 
ematopoiesis that comprises distinct biological sites with differ- 
nt purposes [1] . The endosteal niche, located near the endosteum 
f spongy bone in the metaphysis of long and flat bones, keeps 
SCs predominantly in a quiescent state with high self-renewal 
otency [18] . Besides HSCs, numerous different cell types are part 
f the niche. It is populated with osteoblasts (OBs) that modulate 
SC fate by activation of the Notch-pathway and release of throm- 
opoietin (TPO) in mice [ 19 , 20 ]. An important subset of OBs in the 
urine endosteal niche are spindle shaped N-cadherin expressing 
Bs that partly mediate the interaction with HSCs [21] . In addition, 
steocytes are essential for the mobilization of hematopoietic stem 
nd progenitor cells (HSPCs) mediated through granulocyte colony- 
timulating factor [ 22 , 23 ]. This specific niche provides HSCs with a 
uite stiff matrix ( > 35 kPa) and high ionic calcium and low oxygen 
oncentrations [ 24 , 25 ]. 
The vascular niche, which hosts HSCs in association with the 
inusoidal endothelium, is thought to foster HSCs involved in the 
egular production of blood cells, given its intimate connection to 
he vascular system [ 26 , 27 ]. Apart from the endothelial cells (ECs) 
hat form the inner lining of blood vessels, other relevant cell types 
n this niche include e.g. perivascular mesenchymal stem/stromal 
ells (MSCs) [28] , subtypes of them such as CXCL12-abundant retic- 
lar cells [ 28 , 29 ] and macrophages [30] . These and other niche 
ells present and release important mediators of HSC migration 
nd maintenance, including E-selectin, CXCL12, stem cell factor 
SCF), Leptin and Nestin [ 31 , 32 ]. MSCs are one of the major sup- 
liers of cytokines to HSCs [ 33 , 34 ]. Due to the proximity to blood 
essels, the vascular niche provides a quite soft matrix to HSCs, 
0.3 kPa in the marrow [35] , 0.5–2 kPa in endothelium [36] and 5–
 kPa for the vessel walls [ 37 , 38 ]). Sinusoidal and arteriolar niches 
re described as vascular subniches [ 39 , 40 ]. However, HSC niches 
nd locations seem to be interconnected and are still a matter of 
ngoing research. 
Cell-cell interactions, both direct and indirect, are of vital im- 
ortance in the niche. Direct interactions are mediated mostly 
y the receptors of the cadherin and selectin families [ 18 , 41 , 42 ]. 
oreover, direct cell-cell contact between HSCs and MSCs has 
roven to be important in inducing self-renewal and support- 
ng migratory potential of HSCs [43–45] . Indirect communications 
re mainly conveyed by soluble factors such as cytokines, growth 
actors, hormones and small molecules and they play important 
oles in the HSC niche. SCF is an early acting cytokine, which 
inds to the c-Kit receptor, a receptor tyrosine kinase type III. 
inding of SCF results in an activation of phosphatidylinositol 3- 
inase, JAK/STAT and MAPK pathways. It is known that c-Kit ac- 
ivation through SCF is a very important physiologic regulator of 
SC activity in vivo (reviewed in [46] ). TPO is another impor- 
ant cytokine, which promotes self-renewal and expansion of HSCs. 
PO binds to its receptor cMpl and can activate several differ- 
nt downstream signaling pathways, which seem to be impor- 
ant for the survival and proliferation of CD34 + HSPCs (reviewed 
n [47] ). Fms-like tyrosine kinase 3 ligand (Flt3L), which binds to 
lt3, was observed to support the survival of human HSCs [48] . 
ue to their HSC supporting activities SCF, TPO and Flt3L are 
sed as soluble additives in many HSPC expansion protocols. Be- 
ides these, many other soluble factors, such as interleukin 3 and 
, granulocyte-macrophage colony-stimulating factor, granulocyte 
colony-stimulating factor, CXCL12, transforming growth factor-beta, 
osteopontin, angiopoietin-1 and insulin-like growth factor 1, have 
proven to play a role in the HSC niche ([ 49 , 50 ] and reviewed in
[51] ). 
The extracellular matrix (ECM) of the HSC niche, secreted by 
the niche cells, is composed largely of structural proteins such as 
collagen I and IV, glycoproteins like fibronectin (FN) and laminin 
(LN) and glycosaminoglycans (GAGs, e.g. hyaluronic acid (HA)), 
which consist of chains of repeating disaccharide units. Most GAGs 
are found as a part of proteoglycans with a respective protein core 
[52–54] . Mainly, the integrin family mediates the interaction of 
cells with their surrounding ECM. Integrins are membrane bound 
heterodimeric receptors having several α- and β-subunits, which 
in combination form 24 different types [ 18 , 55 ]. These do not only
recognize specific ECM substrates but also initiate respective cell 
responses [ 4 , 56 , 57 ]. Most importantly, integrins connect the ECM 
with the cytoskeleton and present bidirectional force transmission 
sites, thereby providing the platform for mechanotransduction [4] . 
A well-organized interplay between HSCs, different niche cells 
and the ECM is crucial for a proper niche and thereby HSC func- 
tion. In this context, not only the biological and biochemical com- 
ponents of the niche, but also biophysical conditions like stiffness, 
topography, or shear stress have an impact on HSC fate [ 4 , 25 ]. 
3. Biophysics of the HSC niche 
The mechanobiology of HSPCs is governed both by the ECM of 
the niche and their neighboring cells [ 4 , 58 ]. The sensitivity of cells
towards the ECM stiffness and associated forces not only main- 
tains normal cellular functions and tissue homeostasis but also de- 
termines the differentiation fates of stem cells [ 7 , 59 ]. This is usu-
ally achieved by specific receptor-ligand interactions, which are not 
purely biochemical but can also discern biophysical cues, such as 
matrix architecture, pliability, rigidity and roughness. Simply put, 
cells are simultaneously subjected to various physical, chemical 
and biological stimuli which they can integrate and respond to ap- 
propriately [ 4 , 60 ]. The influence of biophysical parameters in the 
HSC niche is still a topic of ongoing research. HSCs undergo a cer- 
tain degree of deformation while crossing the endothelial barrier 
during transmigration and trafficking. Under these circumstances, 
lamins, which are intermediate filament proteins of the nucle- 
oskeleton, could play a vital role. Shin et al. showed that a certain 
stoichiometry between both isoforms lamin-A and -B contributes 
to human BM-derived CD34 + HSPC transmigration, trafficking and 
differentiation [61] . Mechanical stimuli in cells can not only re- 
sult in prompt responses like adhesion or migration but also in the 
long run, influence expansion and differentiation. Particularly im- 
portant in this context are the transcription factors Yes-associated 
protein (YAP) and transcriptional coactivator with PDZ-binding mo- 
tif, which have been identified as mediators of mechanical sig- 
nals to the nucleus. In a recent study, Lundin et al. used a hu- 
man dorsal aorta-on-a-chip platform to depict that hemodynamic 
YAP-mediated mechanotransduction plays a role in de novo human 
HSPC production [62] . In 2010, Holst et al. showed that increased 
substrate elasticity promoted the expansion of human umbilical 
cord blood (UCB)-derived mononuclear cells (MNCs) and murine 
BM-derived Lineage −Sca1 + c-Kit + (LSK) HSPCs, using tropoelastin, 
a highly elastic biomolecule [ 63 , 64 ]. Several hydrogel studies have 
also revealed the mechanosensitivtiy of HSPCs and are reviewed in 
the chapter 4.3. 
Systems exploring the basic physics of the ECM (geometry, 
stiffness, ligand spacing, micro- and nanotopography) formed the 
grassroot level to investigate the impact of biophysical parame- 
ters on HSPCs. With their help, it was shown that HSPCs are sen- 
sitive to matrix mechanics and shear forces (discussed in chap- 
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Fig. 1. Applications of HSC niche models. One of the most prominent applications of HSC niche models is the investigation of the healthy or diseased niche under well- 
defined conditions (upper left). As artificial HSC niches resemble the in vivo conditions better than standard 2D culture, they allow in vitro drug testing, thereby avoiding 
animal models (upper right). In addition to in vitro HSC expansion (lower left), a diverse range of blood cells, for example, erythrocytes, monocytes, platelets or granulocytes, 
for cellular therapies can be produced with these systems (lower right). (Figure was created with the help of Servier Medical Art by Servier licensed under a Creative 
Commons Attribution 3.0 Unported License). 
Fig. 2. Biophysical parameters influence HSPCs. These include dimensionality and 3D architecture as well as mechanical properties, nanopatterning and topography of the 
environment. Furthermore, shear forces occurring by fluid flow and gradients of soluble factors such as growth factors or cytokines play a role in controlling HSPC behavior. 


















ems (discussed in chapter 6.1) as well as nanopatterning and –
opography (discussed in chapters 4.2 and 5.1) of the environment 
 Fig. 2 ). Studies on time-dependent properties (matrix degradabil- 
ty, viscoelasticity, compressibility, stiffening, surface mobility) of 
he microenvironment, investigation of cell-cell and cell-matrix in- 
eractions, cell polarity, auto- and paracrine signaling as well as 
ddition of soluble factors and other biomolecules enabled deeper 
nsights in the mechanotransduction pathways of other types of 
tem cells and are yet to be determined for HSPCs. [ 40 , 59 , 65 ]. To- 
ether with the in-depth knowledge on the HSC niche biology, fun- 
amental studies on the role of biophysics in the niche form the 
asis for engineering the HSC niche in vitro using biomaterials, 
hich is a complex and multifaceted task. The incorporation and 
nvestigation of more than one niche factor is vital in biomimetic 
iche models. The following chapters take a walk through the dif- 
erent biomaterial-based approaches, their evolution from conven- 
ional 2D cultures to sophisticated 3D systems and give an insight 
into what the future holds for HSC research using biomaterials. An 
overview of the different biomaterials discussed in this review is 
shown in Fig. 3 . 
4. Dissecting the hematopoietic niche complexity in 2D culture 
systems 
4.1. Incorporation of niche components in conventional cultures 
In traditional cell culture [66] , HSCs with a size of approx- 
imately 10 μm in diameter [67] perceive the solid culture ves- 
sel walls as a large, flat 2D surface that is homogeneous in 
composition. Maintenance of HSPCs in vitro is enhanced when 
biological niche components, like cells, ECM proteins or soluble 
factors, are incorporated in the culture container. Since the mid- 
dle of the last century, researchers have utilized feeder-cell lay- e
4 rs to culture mouse BM cells in vitro [68] . It has been shown 
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Fig. 3. The variety of biomaterials offers numerous possibilities for HSC research. Surface coatings by physisorption (A) using ECM-derived molecules or cell-interacting 
motifs such as collagen, FN or LN result in non-specific adsorption, whereas the covalent conjugation of selected biomolecules enables a more defined and specific bio- 
functionalization (B). In general, materials to mimic HSC niches can consist of ECM components that naturally occur in the niche, natural molecules that are not found in 
the niche or synthetic polymers (C). Biodegradable materials (D) can be natural ECM substances with cleavage sites for cell secreted metalloproteases, molecules with weak 
physical bonds or synthetic polymers with incorporated cleavable linkers. Reconstitution of the natural HSC environment, including all aspects of the bone, the soft BM and 
vasculature, can be best mimicked by combining organic (e.g. PEG, PCL, PU) and inorganic (e.g. HAp) biomaterials (E). (Figure was created with the help of Servier Medical 


































hat direct contact between human UCB-derived CD34 + HSPCs and 
M-derived ECs (used as a feeder layer or separated by a microp- 
rous membrane) can regulate proliferation of progenitor cells by 
laboration of lineage-specific cytokines [69] . To date, clinical trials 
ave demonstrated that co-culturing human UCB-derived CD34 + 
SPCs ex vivo with MSCs supported their expansion without loss 
f stemness and significantly improved engraftment when trans- 
lanted into patients [ 70 , 71 ]. Cocktails of cytokines and growth 
actors such as TPO, SCF, Flt3L, IL-3 and IL-6 supplemented to the 
edium can expand the total yield of cells carrying the HSPC 
arker CD34 multifold [72–74] . When such cocktails are com- 
ined with small molecules such as the aryl hydrocarbon recep- 
or antagonist StemReginin1, the pyrimidoindole derivative UM171 
r valproic acid the differentiation of the expanded cell popula- 
ions can be halted [ 73 , 75–77 ]. Recently, polyvinyl alcohol (PVA) 
as identified as a replacement for serum albumin in HSC cul- 
ure. Murine CD34 − LSK HSCs cultured in the presence of PVA, 
00 ng/ml TPO and 10 ng/ml SCF showed increased expansion 
nd maintenance of functional HSC activity ex vivo . Similarly, for 
uman UCB-derived CD34 + HSPCs PVA was shown to be able to 
eplace serum albumin. However, in contrast to murine HSCs, hu- 
an CD34 + CD38 −CD90 + CD49f + HSCs were not sensitive to the 
ydrolysis states of PVA [78] . 
The modification of the culture surface with cellular ligands im- 
tating the surface of a cell layer, ECM molecules or immobilized 
oluble factors offers the possibility to dissect the in vivo niche 
nto molecular pieces. Hence, 2D platforms are well suited to eval- 
ate molecular-driven effects on HSPCs given the simplicity in pro- 
uction and handling, easy access to cells for harvest, monitoring 
nd subsequent analyses, and the potential to scale up for high 
hroughput. 
.2. Biofunctionalized rigid surfaces 
Coatings of culture surfaces with biomolecules is the most 
requently used biofunctionalization technique in 2D culture ap- 
roaches. Either the full-length molecule or, if specific cell- 
interacting motifs are known, shorter versions are tethered, 
whereby engineered fragments can shrink in size to only harbor 
the minimal cell recognition motif and a few flanking groups. Sur- 
face coatings apply a deposition of target biomolecules or its engi- 
neered constructs from solution to the surface by either physisorp- 
tion, electrostatic interaction ( Fig. 3 A) or covalent binding ( Fig. 3 B).
Many ligands suspected to regulate HSPCs have been investigated 
via surface immobilization and will be discussed below in more 
details. 
4.2.1. Non-covalent immobilization 
Ligands of the Notch pathway participate in direct cell-cell con- 
tact. Delaney et al. immobilized the engineered Notch ligand DLL- 
1 ext-IgG together with the FN fragment CH-296 on tissue culture 
plastic (TCP) in varying concentrations. The growth and differenti- 
ation of UCB-derived CD34 + CD38 − HSPCs at moderately low coat- 
ing concentration and the resulting respective surface density in- 
creased the absolute number of CD34 + cells, whereas relatively 
high surface densities induced apoptosis leading to a decreased 
CD34 + cell yield [79] . In phase I trials, these Notch-mediated ex 
vivo expanded CD34 + progenitors were transplanted and could 
successfully engraft in patients [ 80 , 81 ]. 
Investigation of cell-matrix interactions can be realized with 
coated ECM proteins to create adhesive surfaces for cell attach- 
ment. Celebi et al. used culture surfaces coated with either rat 
collagen I, human collagen IV, FN or LN with increasing concen- 
trations of ECM protein solutions and additionally tested two ECM 
protein-mix complexes for UCB-derived CD34 + cell culture. While 
the total nucleated cell (TNC) count did not differ significantly 
between the different individual protein coatings, LN-coatings at 
the lowest concentration showed the most beneficial impact on 
myeloid and megakaryocyte (Mk) progenitor expansions at day 6, 
shown by means of colony forming unit (CFU) assay. A mixed 
coating of all four ECM proteins increased CD34 + cell expansion 
and promoted greater myeloid progenitor expansion than the coat- 
ing mix without collagen I as revealed again by CFU assay [82] . 
ECM proteins of the hematopoietic microenvironment are often in 5  
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lose contact to GAGs of the proteoglycans. Madihally et al. im- 
obilized GAGs onto culture surfaces by forming insoluble ionic 
omplexes with the amino-polysaccharide chitosan. In their study, 
nly chondroitin sulfate B-chitosan and heparin-chitosan complex 
embranes significantly enhanced the expansion of the human 
D34 + population 2 with a maximum growth within the first 2 
nd 4 weeks of culture, respectively. They also colorimetrically 
valuated the partial dissociation of the complexes during cul- 
ure and concluded that soluble GAGs contributed concentration- 
ependently to the observed proliferative effect [83] . 
.2.2. Covalent immobilization 
Coatings based on biomolecule physical adsorption onto TCP 
urfaces can desorb with time under cell culture conditions. Non- 
pecific adsorption is further subject to random orientation of 
he adsorbed biomolecule. More defined biofunctionalized surfaces 
resent aligned and stable biomolecule coupling to the underly- 
ng biomaterial surface that is achieved by covalent conjugation. 
ranke et al. tested a set of different ECM coatings. They cova- 
ently immobilized FN, HA, tropocollagen I, heparin, heparan sul- 
hate, and in addition co-fibrils of collagen I and heparin or HA 
nto thin films of poly(ethylene- alt -maleic anhydride) (PEMA). The 
dherence of human peripheral blood (PB)-derived CD133 + HSPCs 
o these biofunctionalized surfaces was evaluated and no signifi- 
ant adhesion to tropocollagen but a selectin-mediated adhesion 
o heparin and an integrin-mediated adhesion to FN using reflec- 
ion interference contrast microscopy was observed [84] . Moreover, 
N-derived peptides that were covalently immobilized on polymer 
urfaces enabled a higher expansion of human UCB-derived CD34 + 
SPCs 3 [ 85 , 86 ]. 
As cell to material distances are on a nanoscale level (5 to 
0 nm) [87] , studies using well-defined bioadhesive substrates 
evealed the importance of the spatial distribution of ligands. 
ntegrin-dependent cell adhesion of human UCB-derived CD34 + 
SPCs was shown to be dependent on the lateral distance of ECM- 
erived ligands [ 3 , 88 ] accompanied by induced lipid raft cluster- 
ng [3] as well as the size of the nanopatterned ligand [88] . While 
CM-derived ligands require a nanotopographical presentation to 
fficiently mediate responses in HSPCs, cellular ligands such as 
LL-1 are dependent on their density to enable receptor cluster- 
ng for promoting the expansion of human UCB-derived CD34 + 
SPCs as observed by flow cytometry and cell enumeration [89] . 
hese studies underscore the importance of paying attention to the 
anoscale features in functionalized materials when designing sub- 
trates for HSPC culture. The use of fibers is another approach to 
chieve nanotopographical structures. These can imitate the fibrous 
CM proteins and will be discussed in chapter 5.1. 
.3. Biofunctionalized elastic substrates 
Rigid surfaces typically used for cell culture, e.g. polystyrene 
asks, are often hydrophobic, whereas typical biocompatible softer 
urfaces are of hydrophilic nature. Hydrogels are hydrophilic poly- 
er networks that retain a significant fraction of water [90] . There- 
ore, they are often used to investigate 2D soft surfaces. HSPCs are 
ensitive to the mechanical properties of the underlying culture 
ubstrate. Conventionally used cell culture substrates are highly- 
igid surfaces (elastic modulus of glass ~70 GPa [91] ) that is why 
ovalently crosslinked hydrogels are most commonly employed to 
tudy substrate stiffness effects. This stems from the advantage 
hat hydrogel formulations can be adjusted to cover the range 
f physiologically relevant values of substrate elasticity found in 
BM. Elasticity sensing and responsiveness of HSPCs to substrates 
was explored by the culture of murine LSK HSPCs on top of 2D 
collagen-coated polyacrylamide (PA) substrates. Analysis of 2D mi- 
croscopy images (computation of spread area and cell shape in- 
dex of the cells), showed that the stiffer the substrate and the 
higher the collagen ligand density, the more spread the cells are 
[92] . Stiffness-dependent cell morphological changes could further 
be confirmed with different ligand types, namely collagen I, FN or 
LN. Murine LSK HSPCs cultured on soft gels remained rounded, 
whereas on stiffer substrates, they appeared more polarized and 
spread [93] . For human HSPCs, cell adhesion and motility are in- 
fluenced by the stiffness of FN-functionalized hydrogels. Manual 
tracking of HSPCs in time-lapse movies showed that they adhered 
better and migrated further on stiffer hydrogels [94] . Apart from 
that, stiff FN-coated substrates maintained most primitive myeloid 
progenitors in short-term (24 h) culture, whereas stiff LN-coated 
substrates promoted differentiation towards erythroid lineages 4 in 
comparison to their respective softer substrates [93] . The same 
study substantiated that the effect of FN on the maintenance of 
primitive HSPCs versus induction of differentiation is controlled by 
intracellular tension and a selective engagement of integrin recep- 
tors [93] . Conclusively, only enabling cell adhesion is not sufficient 
for HSPC maintenance in vitro , but it ensures close proximity to the 
substrate and its inherent properties. In this line, a poly(ethylene 
glycol) diacrylate (PEG-DA) hydrogel surface proved the interplay 
of immobilized soluble factors, SCF and IFN γ , in combination with 
the cell adhesion ligands RGDS and connecting segment 1. Both, 
the combination of RGDS and SCF or RGDS and IFN γ promoted 
proliferation and maintenance of murine HSPCs [95] . 
5. Heading for the next dimension: from 2D to 3D 
5.1. Nanofibers 
Nanofibers (NFs) can be termed a stepping stone from 2D to 3D 
culture and have been widely used in the past two decades due 
to their ability to mimic the ECM structure of many human tis- 
sues, including BM [96] . Several strategies have been used to pro- 
duce NFs, e.g. phase separation, self-assembly and electrospinning 
[97] . Among them, electrospinning has been of major interest ow- 
ing to its ability to produce NFs similar to the fibrous structure of 
ECM, the ease of controlling their diameter, its applicability for a 
wide range of materials and cost-effectiveness. Natural polymers, 
e.g. collagen, silk, gelatin and elastin or synthetic polymers such as 
polycaprolactone (PCL), poly(glycolic acid) (PGA), poly(L-lactic acid) 
(PLLA), poly(lactic-co-glycolic acid) (PLGA) and polyurethanes (PU) 
have been used in NF fabrication [98] but they all have advan- 
tages and disadvantages. While natural polymers, in general, have 
a good biocompatibility and hydrophilicity, they suffer from weak 
mechanical properties and low processability. Synthetic polymers, 
in contrast, have good mechanical properties and offer greater flex- 
ibility to tune their properties during synthesis or post polymeriza- 
tion modification, but they are mostly hydrophobic and have low 
cell affinity due to the lack of cell-binding sites [99] . To overcome 
these challenges, many approaches have been tested. Chemical sur- 
face treatment has been done to introduce functional groups onto 
the surface of synthetic polymer NFs. Human CD34 + HSPCs cul- 
tured on aminated polyethersulfone NF meshes showed stronger 
adherence as well as greater expansion and maintenance of mul- 
tilineage progenitors 5 compared to HSPCs cultured on unmodified, 
hydroxylated, or carboxylated NF meshes or aminated films [100] . 
This study demonstrates that even simple surface chemistry can 2 Cell phenotype analyzed by flow cytometry. 
3 Cell phenotype analyzed by flow cytometry and differentiation potential as- 
essed by CFU assay. t
6 4 Differentiation potential assessed using CFU assay. 
5 Phenotypic analysis was performed using flow cytometry (CD34, CD45) and 
heir differentiation potential was shown using CFU assay. 
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ffect HSPCs in the microenvironment. Many studies suggest the 
oating of synthetic polymer NFs with natural polymers, such as 
N or collagen, to increase the biocompatibility of the fibers for 
uman UCB-derived CD34 + HSPCs [101] . It was also shown that 
he large surface area-to-volume ratio provided by PCL-NF and the 
ell-binding domain of FN or collagen promoted cell-cell and cell- 
atrix interaction and resulted in higher cell proliferation com- 
ared to TCP 4 [102] . Expansion of BM-derived HSCs could also be 
nhanced by using NFs prepared from a PLGA/collagen I blend. In 
his study, coating blended NFs with E-selectin raised the efficiency 
f capturing HSCs [103] . Co-culturing human UCB-derived CD133 + 
SPCs with MSCs on these PLLA NFs was able to further increase 
he expansion of CD133 + HSPCs [104] . Batnyam et al. designed 
 biohybrid, beehive-like 3D scaffold composed of three overlaid 
ayers [105] . Each layer was covered with PU electrospun fibers, 
hich aligned during the fabrication process to result in two types 
f scaffold either transversely isotropic (scaffold I) or anisotropic 
scaffold II). Both scaffolds were seeded with MSCs as a feeder 
ayer. Scaffold II showed a significant increase of JAG1 expression 
n MSCs compared to scaffold I. Both scaffolds, however, enhanced 
he proliferation of human CD34 + and CD34 + CD38 − cells com- 
ared to the 2D control culture. 
Although using NFs can be considered as a step forward in cap- 
uring the fibrous structure of the ECM, it is not sufficient to mimic 
he hierarchical structure of this niche, including the spatial distri- 
ution of different biomaterials and cells surrounding the HSCs. 
.2. Microcavities 
Mechanically soft hydrogel layers can exhibit an elastic creas- 
ng instability of their 2D surface. This microtopography formed as 
 result of surface creasing can affect in vitro cell behavior [106] . 
xtending the cell-substrate contact area to precisely trap one cell 
an in turn be utilized for sorting HSPCs [107] . The underlying 
orrelation between migration behavior, lodgment and stem cell 
aintenance can better be observed by single cell culture in mi- 
rocavities. Single human PB-derived CD133 + HSPCs adhering in- 
ide FN-functionalized microstructures were found to slow down 
ell cycling as detected by BrdU incorporation and cytometric anal- 
sis [108] . A reduced expansion was found for adherent human 
D133 + HSPCs in collagen I- and heparin-functionalized microcav- 
ties, with the effect being more pronounced on collagen I 6 [109] . 
he spatial constraints were assumed to maintain isolated murine 
in − HSPCs in a quiescent and multipotent state 1 which is vital 
or repopulation of a depleted hematopoietic system [110] . On the 
ther hand, allowing direct HSPC cell-cell contact and unhindered 
ara- and juxtacrine signaling in multicell-sized microcavities re- 
ulted in higher expansion of human CD34 + HSPCs than in sin- 
le cell-sized cavities, even on a soft background [111] . In these 
rtificial single cell niches, individual HSPCs explore spatial con- 
nements that are defined by substrate stiffness, ECM ligand type, 
ensity and spatial distribution, as well as available soluble fac- 
or levels – all found in a 3D environment. Within recent years, 
ngineered HSPC culture substrates intensively focused on 3D en- 
ironments to resemble the natural niche more closely. Many 3D 
iomaterial-based models convincingly expanded and maintained 
SPCs more efficiently compared to a 2D substrate. 
. Recreating the hematopoietic niche using 3D systems 
.1. Hydrogel-based models 
Hydrogel-based systems are one of the most promising tools 
tilized in mimicking the 3D environment in in vitro cultures. 
There are several reasons why researchers favor 3D hydrogels for 
designing experiments to study the HSC niche. To begin with, they 
can imitate the biophysics of the ECM (stiffness, architecture), en- 
able the signals which are generated during cell-ECM interactions 
and finally provide scope for remodeling [112] . Next, they pro- 
vide a 3D environment in which the cells can form contacts to 
the matrix and maintain their natural shape, without polarizing 
in a non-physiological way as in 2D cultures [112] . Furthermore, 
they support cell-cell communication [113] and mimic the influ- 
ence of the niche ECM on diffusion and concentration gradients of 
soluble components, such as signaling and waste molecules, bet- 
ter than 2D systems [114] . Finally, hydrogel properties are quite 
tunable which makes them advantageous for certain applications 
or analysis methods. The use of hydrogel-incorporated systems in 
the field of biomaterial-based in vitro studies is vast and diverse. 
Therefore, we will highlight some studies in the text and give an 
overview of selected studies in supplementary Tables S1 and S2. 
Organic molecules used to fabricate hydrogels for 3D ap- 
proaches can be natural niche ECM components (e.g. Matrigel ®, 
collagen, fibrin; see suppl. Table Sections 1.1 and 2.1), natural non- 
niche ECM molecules (e.g. alginate, chitosan, pullulan, cellulose, 
silk; see suppl. Table sections 1.2 and 2.2) or synthetic polymers 
(e.g. PEG, PU, PLGA, PCL; see suppl. Table Sections 1.3 and 2.3) 
( Fig. 3 C). However, the line between the categories blurs when 
blends of synthetic and natural polymers are used (e.g. star-PEG 
and heparin [115] HA, gelatin and PEG-DA [116] (suppl. Table Sec- 
tions 1.4 and 2.4)) or when natural polymers are synthetically 
modified (e.g. gelatin methacrylate (GelMA) [117–119] or cationized 
bovine serum albumin [120] (suppl. Table Sections 1.1 and 2.1)). 
It is not only the diverse array of available materials that makes 
hydrogels an interesting platform but also the multitude of tech- 
niques one can apply in their preparation. Each technique results 
in a different kind of hydrogel, some of which will be discussed in 
the subsequent chapters. 
6.1.1. Approaches to mimic the 3D environment of HSPCs with 
hydrogels 
The ways in which hydrogels are used to provide a 3D environ- 
ment for HSPCs can be subdivided into two main approaches – en- 
capsulation of cells within the gels or using them as macroporous 
scaffolds into which cells can be seeded. While the first approach 
is suited to recreate the interaction of HSPCs with the ECM of the 
soft BM, macroporous scaffolds mimic the porous architecture of 
cancellous bone, which hosts the niche-harboring red BM. 
During encapsulation cells are mixed with a precursor solu- 
tion, which is then crosslinked around the cells so that the cells 
are completely enveloped by the matrix. This ensures that the en- 
tire surface of the cell is in contact with the biomaterial. As cells 
are present during the crosslinking, this technique requires non- 
cytotoxic methods. Often, soft hydrogels are applied in such ap- 
proaches, which resemble the soft ECM of the BM [112] . An impor- 
tant factor of encapsulation is the mesh size of the polymer net- 
work, which influences the stiffness of a gel as well as the diffu- 
sion of small molecules [121] including the disposal of waste sub- 
stances, the supply by nutrients and oxygen [122] and the signaling 
between cells. The Harley group developed hydrogels with differ- 
ent mesh sizes, which supported either paracrine (big meshes) or 
autocrine (small meshes) signaling and studied the effect on the 
cells. They showed that murine LSK HSPCs proliferated more in 
a paracrine signaling supporting GelMA matrix when kept alone, 
but the expansion was much higher when HSPCs were co-cultured 
with MSCs in an autocrine signaling supporting gel [118] . Some- 




7 uch as in collagen gels, which closely resemble the microscale ar- 
hitecture of the ECM [125] (more examples discussed in suppl. 
able S1). 
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Macroporous hydrogels have a structure with interconnected 
ores that are large enough to harbor cells. The cells present in the 
ores have less contact to the surrounding material and a greater 
ontact to the medium compared to encapsulating systems but can 
till maintain a natural shape [126] . If designed with appropriate 
tiffness and architecture, porous scaffolds resemble the trabecu- 
ae of the cancellous bone. Therefore, they can be used to create a 
epresentation of the endosteal niche. In such systems, the scaffold 
s first prepared and then the cells are added. Hence, contrary to 
ncapsulation gels, porous structures are usually prepared under 
arsh conditions. To produce the porous complexes, several tech- 
iques are used, such as emulsion templating [127] , phase separa- 
ion [128] , salt leaching [ 126 , 129–131 ], cryogelation [ 120 , 132 , 133 ], 
lectrospinning [134] , 3D printing [135] or inverted colloidal crys- 
al (ICC) templating [ 136 , 137 ]. 
Congruent to the mesh size in encapsulating hydrogels, pore 
ize, porosity and interconnectivity of the pores play an important 
ole in these systems. In general, it has been observed for certain 
ell types, such as MSCs and OBs, that the pore size and poros- 
ty influence proliferation, differentiation, migration and aggregate 
ormation [138] . Taqvi et al. observed that a decreasing pore size 
ncreases hematopoietic differentiation of murine embryonic stem 
ells [139] . Some of the effects arising from high porosity might be 
ue to a higher nutrient and oxygen transport [138] . Exchange of 
oluble factors in macroporous scaffolds can be enhanced by intro- 
ucing a medium flow into the system, which was shown to influ- 
nce HSPC fate in co-cultures with MSCs [ 130 , 131 , 133 , 140 ]. Rödling 
t al. showed that perfusion of macroporous scaffolds led to an en- 
anced exchange of hematopoietic cytokines released by the inher- 
nt cells which fostered differentiation of human CD34 + HSPCs 2 
130] . Some studies have demonstrated that non- or very slowly 
erfused setups can be used to mimic the endosteal niche and 
romote HSPC expansion, whereas perfused cultures resemble the 
ascular niche and support differentiation and blood cell produc- 
ion [ 130 , 131 , 133 , 140 ] (more studies in suppl. Table S2). 
To capture the chemical complexity of the ECM in in vitro cul- 
ures is a challenging task. In this context, the use of decellularized 
atrices is worth mentioning as it is an approach to produce hy- 
rogels from a biological source. These scaffolds are derived from 
issues or organs in which the cellular contents have been elimi- 
ated, but the ECM composition and 3D structure are preserved. 
ence, they are biocompatible and retain certain biological activ- 
ties [141] . After the decellularization process, the tissues can be 
sed as macroporous scaffolds (see suppl. Table Section 2.5). 
The majority of these studies have observed that a more prim- 
tive HSPC subpopulation is maintained in 3D hydrogel systems 
ompared to 2D cultures. In some studies, the 3D expanded HSPCs 
ere able to engraft and repopulate in mice [ 132 , 142–144 ]. Some 
ave also succeeded in achieving lineage-specific differentiations 
 123 , 124 , 136 , 137 , 145 ]. The important observations and results ob- 
ained from these studies are briefly summarized in suppl. Tables 
1 and S2. 
.1.2. Tunable Hydrogel Properties for HSPC culture 
In addition to providing a 3D architecture, hydrogels also al- 
ow the adjustments in their biochemical functionalization, me- 
hanical properties and degradability to resemble the natural 
rchetype. Similar to 2D, synthetic polymers in 3D hydrogels need 
o be modified with cell adhesion motifs to accommodate effi- 
ient cell-material interactions. This can be accomplished by coat- 
ng a porous scaffold with ECM molecules [ 101 , 134 , 146 ] or by in- 
orporating ECM molecules [147] or only small peptide sequences 
 126 , 129 ] into encapsulating or macroporous hydrogels. As dis- 
ussed in chapter 2, natural ECM molecules not only provide 
inding sites and facilitate cell adhesion but also trigger signal- 
ng pathways. In synthetic systems, researchers can select the de- 
sired biomaterial and functionalization and hence control the sig- 
nals generated by the artificial ECM, tailored to suit the aims of 
the study. Some examples are the functionalization with Jagged- 
1 [127] , Delta-like ligand-1 (DLL-1) [136] , SCF or IFN γ [ 95 , 148 ].
In the natural environment of HSPCs, signals such as chemokines 
[ 29 , 149 ], calcium [150] and oxygen [151] can guide the motion 
of HSPCs. They are often present in hotspots [152] or gradi- 
ents [153] . Mahadik and colleagues could generate cell density 
gradients and signaling factors in 3D murine LSK HSPC cultures 
[ 148 , 154 ]. Marturano-Kruik et al. introduced an oxygen gradient in 
a human bone perivascular niche-on-a-chip using MSCs, ECs and 
breast cancer cells (BCC) [155] . 
Similar to 2D systems, matrix stiffness influences the fate of 
HSPCs in 3D as well. Zhang and co-workers reported a higher ex- 
pansion of murine LSK HSCs 1 in stiffer collagen gels compared to 
softer hydrogels with a stiffness lower than 100 Pa (14.64 and 
36.96 Pa) [156] . In contrast, Gvaramia et al. observed a reduced 
human CD34 + HSPC expansion 7 with increasing stiffness of a star- 
PEG heparin gel in ranges much higher than 100 Pa (0.5–3 kPa) 
[115] . 
Biodegradable materials are used to mimic the remodeling of 
the natural ECM [118] ( Fig. 3 D). These can be either natural compo- 
nents of the ECM, which have cleavage sites for cell-secreted met- 
alloproteases (e.g. collagen and collagenase) or synthetic polymers 
with incorporated cleavable linkers [ 95 , 115 , 118 , 142 ]. Bai et al. used
zwitterionic hydrogels with peptide cleavage sites to expand hu- 
man UCB- and BM-derived HSPCs for several generations. A 73-fold 
increase of long-term HSCs could be reached as well as a reconsti- 
tution for at least 24 weeks in immunocompromised mice (details 
of evaluation methods in suppl. Table S1 Section 1.3) [142] . 
Another feature of some materials in HSPC culture is the abil- 
ity to regain the original shape after having been compressed. This 
attribute is used to generate injectable scaffolds [157] (see suppl. 
Table S2 Section 2.4). Tavakol and colleagues were even able to 
create an artificial in vitro system with different niche cells and 
factors, which could be completely injected while maintaining in 
vitro generated ECM molecules and cell-cell contacts [132] . 
6.1.3. From hydrogels to more complex niche mimetics 
Mimicking the niche requires the combination of its chemical 
and biological components while ensuring appropriate biophysical 
properties. It was shown that some effects on HSPCs only arise if 
two or more properties of the system are combined [ 118 , 126 ]. It
is not possible to achieve this task only by hydrogel systems. For 
a near complete representation of the natural HSC microenviron- 
ment in vitro , aspects of the bone, the soft BM and vasculature 
should be considered by combining inorganic (discussed in chap- 
ter 6.2) and organic materials ( Fig. 3 E). Additionally, one should 
take into account the biophysics of the niche by including medium 
flow, appropriate 3D architecture, niche cells as well as chemical 
niche factors including ECM molecules and cytokines. An attempt 
towards this goal was made by Bourgine et al. in 2018 by com- 
bining an inorganic scaffold modified with ECM by stromal cells 
in a bioreactor which resulted in an artificial BM system that sup- 
ported HSPC maintenance [140] . Hydrogels in combination with 3D 
bioprinting (discussed in chapter 6.3), on-a-chip devices (discussed 
in chapter 7) and bioreactors [ 145 , 158 ] (more examples in suppl.
Table S2) could bring us a step closer to achieving a model which 
would recapture the niche complexities to a higher extent. Some 
researchers have already used 3D printed grids as macroporous 
scaffolds with favorable results [ 134 , 135 ]. In 2018, Braham et al. 
designed the endosteal and vascular HSC niche using 3D bioprint- 
ing and studied the survival and proliferation of primary human 
7 Cell phenotype analyzed by flow cytometry (CD34 + , CD133 + ) and differentia- 
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M-derived CD138 + myeloma cells. They used a bioprintable pasty 
alcium phosphate (CaP) cement scaffold seeded with osteogenic 
SCs to model the endosteal niche and endothelial progenitor 
ells and MSCs encapsulated in Matrigel ® to model the perivascu- 
ar niche. The resulting system highlighted the importance of the 
erivascular niche in supporting myeloma cells. This study is an 
mportant example of an integrated 3D system, which makes use 
f both organic and inorganic substances and combines 3D print- 
ng technology with encapsulating hydrogel systems to mimic the 
iche [135] . 
.2. Inorganic materials used in BM scaffolds 
The bone is constantly and dynamically remodeled, a process 
ainly controlled by osteoclasts (OCs) resorbing calcified bone ma- 
erial and by OBs rebuilding the bone matrix. As OBs are known 
o regulate HSC functions [ 19 , 20 , 159 ], materials that mimic highly 
alcified bone and enable the in vivo processes of bone remodeling 
re needed to realize such processes in vitro . Inorganic materials 
re best suited to fulfill these criteria. Bone is mainly composed of 
ollagen fibers being mineralized by hydroxyapatite (HAp), which 
onsists of CaP. A biomimetic material hosting OBs and OCs should 
herefore contain CaP. Till date, there are different materials with 
iverse CaP phases available in the form of bone pastes, cements, 
njectable foams, 3D-printed scaffolds, coatings or nanoparticles 
reviewed in [160] ). Besides CaP, other phosphates such as mag- 
esium phosphate have been established as suitable bone replace- 
ent materials [161] . Along with classical phosphate materials, 
lso scaffolds made of calcium silicate or bioactive glass have been 
eveloped [162–165] . In addition to calcium and magnesium there 
re other inorganic ions present in bone, such as zinc [166] , stron- 
ium [167] or manganese [168] , which therefore have been in- 
orporated into bone mimicking materials as well. These diverse 
ubstances in all their possible blends lead to a great variety of 
one-mimetic materials, which is even expanded as these inor- 
anic materials can also be combined with organic substances. By 
dding polymers to a CaP cement, the setting time of the paste, 
ashout resistance, injectability, macroporosity, mechanical prop- 
rties, long-term degradation and drug release properties of the 
aterial can be varied [169] . In theory, all inorganic materials 
hich are being successfully used in biomedical applications or 
one remodeling studies can be adapted for hematopoietic en- 
osteal niche models to mimic the cancellous bone. In these mod- 
ls, besides HSCs, supporting niche cells such as MSCs or OBs are 
lso seeded into these scaffolds. It was shown that MSCs from 
M and adipose tissue cultured on porous HAp scaffolds, produced 
y foam-gel technique, were able to support murine c-Kit + HSPC 
aintenance in mice post transplantation [ 170 , 171 ]. For biphasic 
aP scaffolds it was shown that human CD34 + HSPC adhesion and 
he formation of proliferating colonies 3 is dependent on the stoi- 
hiometry of HAp and β-tri CaP; the best results were obtained on 
 material composed of 50% HAp and 50% β-tri CaP [172] . Com- 
osite materials of magnesium-doped HAp and collagen I, which 
ormed a porous and highly fibrous structure, were transplanted 
nto rabbits. They induced the formation of trabecular and corti- 
al bone-like tissue and supported the formation of an osteogenic 
s well as a hematopoietic niche [173] . Zhang et al. used bipha- 
ic calcium-infiltrated HAp foams, in which they co-cultured hu- 
an Lin −CD34 + CD38 − HSPCs and OBs and showed that calcium- 
nfiltration improved HSPC maintenance 2 most likely due to in- 
reased local calcium concentrations [174] . Schmelzer et al. em- 
edded an open-porous HAp layer between hollow-fiber mem- 
rane layers, which was set-up in a perfusion bioreactor. Therein 
hey cultured human BM-derived MNCs, which turned out to be 
etabolically more active compared to static culture conditions. 
he long-term maintenance of human Lin −CD34 + CD38 − HSPCs 2 
was found to be enhanced by this system [175] . The best mimicry 
of bone, however, is provided by nature itself which is why the us- 
age of decellularized bone for modeling the niche [155] and HSPC 
culture [176] is not uncommon. Using this material a maintenance 
and expansion of human CD34 + CD38 − HSPCs could be achieved 2 
[ 176 , 177 ]. 
6.3. Bioprinted scaffolds 
3D bioprinting can be defined as precise positioning of bio- 
materials and living cells using an automated computer-aided 
layer-by-layer deposition approach to fabricate a 3D functional liv- 
ing tissue or organ [178] . It is a promising technique for a wide
spectrum of applications and research fields [179] . This technique 
allows scientists not only to fabricate scaffolds with specific geo- 
metric shapes using one or more types of biomaterials and cells 
but also gives them the spatial control over the distribution of 
these materials and cells within the printed scaffold. Muerza- 
Cascante et al. fabricated a model to mimic the endosteal mi- 
croenvironment using 3D melt electrospinning writing technology 
[180] . In this study, the authors fabricated a 10-layered scaffold 
with 10 0–20 0 μm pores using PCL-NF. Therein, primary human 
OBs were cultured under osteogenic conditions for 35 days fol- 
lowed by introduction of HSCs for 5 days using cytokine-free and 
cytokine-containing conditions. The addition of cytokines signifi- 
cantly increased the number of CD45 + cells in the 3D co-culture 
and supported a higher ratio of expansion compared to 2D. Kang 
et al. prepared a hierarchical scaffold by using 3D printing (rapid 
prototyping) together with electrospinning, followed by a coating 
of FN or collagen I for the ex vivo expansion of human UCB-derived 
CD34 + HSPCs. PCL mixed with 10% (w/v) HAp was used for print- 
ing the main body of the scaffold and PU was electrospun onto 
each layer of the scaffold during the process. Later, the surface of 
the scaffold was treated either with FN or collagen I while the 
TCP remained untreated. The scaffold coated with FN showed the 
highest number of TNCs (164-fold), highest ratios of CD45 + CD34 + 
(35%) and CD34 + CD38 − (32%) populations 2 after 7 days in cul- 
ture [181] . In another study, a similar scaffold treated with vit- 
ronectin instead of FN was used to study the effects of applying 
intermittent hydrostatic pressure as a kind of mechanical stimu- 
lus on the expansion of human UCB-derived CD34 + HSPCs 8 . The 
results revealed that the combination of the hierarchical structure 
and physical stimulation could enhance ex vivo expansion of HSPCs 
while maintaining their phenotypic characteristics [134] . Although 
the number of studies related to the application of 3D bioprinting 
for HSCs is relatively low, this technique is quite encouraging for 
scientists who aim to develop a hierarchical 3D scaffold, which is 
able to mimic the microenvironment of the HSC niche. 
6.4. Approaches to mimic the vascular HSC niche 
Probably due to the later discovery of the vascular niche 
[ 39 , 182 ], most studies mimicking the human HSC niche recap- 
ture the endosteal niche. When mimicking the vascular niche, 
the multitude of different cell types and the biophysical prop- 
erties characteristic of this microenvironment, e.g. the need for 
softer substrates compared to endosteal niche models, have to be 
considered [ 93 , 183 ]. Additionally, the development of a functional 
microvascular network and sufficient vascularization throughout 
the material is crucial for an appropriate vascular niche model 
but difficult to achieve. Despite these challenges, there are a few 
promising approaches in capturing the complexity of the vascular 
8 Observations were based on flow cytometric analysis of CD34 + CD38 - popula- 
tion, CFU and LTC-IC assays. 9  
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iche. ECs play an important role in the vascular niche. They have 
een shown to tightly interact with HSPCs and to enhance their 
ong-term expansion, engraftment, differentiation and regeneration 
 1 , 184–188 ]. Introduction of the adenoviral E4ORF1 gene into ECs 
ugments their cultivability while maintaining their HSPC support- 
ng properties [ 189 , 190 ]. Many studies use co-cultures of MSCs and 
Cs as their close interaction is essential when it comes to neo- 
ascularization and the formation of a stable vasculature [ 191 , 192 ]. 
he combination of ECs and MSCs in an appropriate scaffold en- 
bles the generation of pre-vascularized bone or tissue with a net- 
ork of vessel-like structures [ 193 , 194 ]. 3D culture systems using 
iomaterials as platforms, incorporating HSPCs with stromal cells 
nd relevant ECs, would be an ideal approach for biomimicry of 
he vascular niche. 
The work of Yang et al. [195] underlines the importance of us- 
ng MSCs and ECs for a vascular niche model as they observed en- 
anced vascularization, the formation of more capillary-like tubes 
nd positive effects on osteogenesis in the co-cultured samples. 
hey incorporated human vascular ECs and human BM-derived 
SCs into an in situ forming and injectable double-network hy- 
rogel, which was characterized by a condensed polymer network, 
nhanced mechanical properties and lower degradation kinetics 
ompared to the respective single-network hydrogels. Another ad- 
antage of the used hydrogel is the reversibility of the crosslinks, 
hich enables the proliferation of the cells within the network 
tructure. Even though this hydrogel was not tested with HSPCs 
o far, it is an encouraging approach meeting some of the above 
ddressed requirements and could serve as a supportive niche-like 
ative ECM model. Another study closely mimicking the BM vas- 
ular architecture included controllable shear forces and flow rates 
sing a perfusion bioreactor system aiming for an ex vivo platform 
or human platelet generation from Mks [133] . Tozzi et al. fabri- 
ated porous, spongy scaffolds out of silk fibroin and achieved cell 
eeding and perfusion through channels of 0.5 or 1 mm diame- 
er. The fabricated silk sponge was mounted into the bioreactor 
nd the Mks were seeded into the channels. After 36 h, the biore- 
ctor was connected to a pump and platelets were collected due 
o applied shear forces. With this multi-channel vascular system, 
hey could imitate the structure and flow dynamics of BM capil- 
aries. The incorporated channels enabled perfusion and the pro- 
ession of large amounts of cells combined with a highly porous 
caffold that provides a large surface area for cell attachment. Fur- 
her development of this system could also incorporate HSCs or 
Cs, thus stepping towards a more complex model of the vascular 
iche. Another interesting approach provided a perfusable 3D mi- 
rovessel system to mimic the perivascular niche [196] . The 3D mi- 
rofluidic system consisted of a collagen I gel with uniformly em- 
edded BM-derived fibroblast cell lines or MSCs creating a 100 μm 
iameter network. By perfusing the channels of this network with 
uman umbilical vein endothelial cells (HUVECs), which adhered 
o the collagen, functional microvessels formed. After cultivating 
he fabricated vessels for 3-4 days, healthy or leukemic human 
D34 + cells were added to the EC-MSC/BM-derived fibroblast cell 
o-culture via perfusion through the channels. With this model, 
otha et al. were able to demonstrate the dynamics of the mul- 
icellular interactions that they additionally could spatiotemporally 
ontrol and change. 
. Bone marrow-on-a-chip 
In terms of complexity, one is only limited by imagination. 
 very high complexity is achieved in multicellular and self- 
rganizing organoids, which represent life-like models [ 197 , 198 ]. 
o create dynamic culture conditions and get closer to reality, such 
ulticellular tissue arrangements were cultured in microfluidic 
evices to generate so-called organs-on-chips [199] . These mod- 
els consider 3D architecture, cell-cell and cell-matrix interactions 
and allow a permanent perfusion with cell culture medium. Tori- 
sawa et al. were able to establish a BM-on-a-chip, in which they 
achieved the cultivation of murine LSK HSPCs for at least a week 
in in vivo -like proportions. To do so, they implanted a collagen I 
gel comprising demineralized bone powder into mice and received 
a nearly true-to-nature engineered BM containing HSPCs and their 
progeny 9 . This BM was afterwards surgically removed and placed 
in a microfluidic device, where the BM was supplied with nutri- 
ents [200] . Later, Sieber et al. developed a human cell-based BM- 
on-a-chip model. MSCs from BM and HSPCs were seeded on an 
HAp-coated zirconium oxide ceramic scaffold and transferred into 
the microfluidic device. With this system a long-term culture of 
up to 28 days of primitive human CD34 + CD38 − HSPCs was en- 
abled [201] . Aleman et al. also used a human cell-based system 
but deconstructed the HSC niche into the following four niche con- 
structs: periarterial using arterial ECs, perisinusoidal using sinu- 
soidal ECs, mesenchymal using MSCs and osteoblastic using os- 
teogenically differentiated MSCs. All of the cells were encapsu- 
lated in a hydrogel consisting of HA and gelatin and placed into 
four separate chambers of a microfluidic device. Healthy or ma- 
lignant HSPCs were infused by a circulating channel system. Hu- 
man CD34 + HSPC interactions with the four different niche con- 
structs could be monitored in real-time using a cell tracking tech- 
nology [116] . Different niche models combined in one device were 
also used by Chou et al. They created a system that could balance 
proliferation, multilineage differentiation and continued progeni- 
tor survival while also improving CD34 + cell maintenance com- 
pared to conventional culture methods [202] . They fabricated a 
poly-di-methyl-siloxane (PDMS) chip consisting of two chambers 
connected through a porous membrane. The top “hematopoietic”
chamber was filled with a 3D co-culture of human CD34 + HSPCs 
and BM-derived MSCs in a fibrin gel representing the endosteal 
niche. The bottom “vascular” channel, which was lined by HUVECs, 
assured perfusion of the system with medium containing support- 
ing cytokines. This model spatially mimicked the endosteal and 
the vascular niche simultaneously, separating them locally. Further- 
more, the perfusion was only obtained through the vascular chan- 
nel similar to the delivery of nutrients throughout the vasculature 
in vivo . 
8. Biomaterial-based approaches in hematopoietic 
differentiation 
The in vitro production of blood and immune cells holds 
great promise in the field of regenerative medicine [ 203 , 204 ], im-
munotherapy [205] and transfusion medicine [206] . Despite the 
small proportion of CD34 + cells in BM (1–3%), UCB (~1%) and PB 
( < 0.1%) [207] , HSCs remain a good starting point for the directed 
in vitro blood production. However, since HSCs are mainly obtained 
from blood donations, applications for in vitro differentiation are 
limited by their small number [207] and new strategies have to 
be developed to make current differentiation protocols more effi- 
cient. The in vitro production of blood cells from HSCs is a promis- 
ing strategy to gain new insights into the biology of hematopoi- 
etic differentiation. It has the potential to make a major contri- 
bution towards the availability of safe blood cells [ 208 , 209 ], im-
proved and eventually personalized treatment options and the con- 
comitant reduction of transfusion induced adverse reactions [210–
212] . In the last few years, a lot of improvements in the ex vivo
9 Cell phenotype analyzed by flow cytometry; mature, lineage-restricted 
blood cells (Lin −Sca1 + cKit + CD34 + / −, Lin −Sca1 + cKit + CD150 + / −CD48 −/ + ), hematopoi-
etic progenitor cells (Lin −Sca1 + , Lin −cKit + , Lin −CD34 + , Lin −CD135 + ), mature ery-
throcytes (Ter119 + ), lymphocytes (T cells-CD45 + CD3 + ; B cells-CD45 + CD19 + ) and 
myeloid cells (CD45 + Mac1 + / −Gr1 + / −). 10  
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eneration of HSC-derived Mks and platelets in different types of 
erfusion systems, cellular interpenetrating network hydrogels and 
M-mimicking biocompatible scaffolds were made, and have been 
xtensively reviewed elsewhere [9–11] . To circumvent the limited 
vailability of donor-derived red blood cells (RBCs), effort s have 
een made to establish new designs for large-scale blood produc- 
ion with the introduction of several bioreactor-based culturing de- 
igns [213–215] . Nevertheless, these approaches are not optimal 
s under these culture conditions HSCs are pushed into lineage 
ommitment and rapidly exhaust the initial stem cell pool, which 
aises the costs of in vitro production many times over donor-based 
ransfusion [216] . 
In general, there are two different methods aiming to over- 
ome these issues: (i) the reduction of added supplement con- 
entrations [128] and (ii) the development of a self-sustaining dif- 
erentiation system [ 127 , 217 ]. However, the avoidance of cytokine 
timulation might be disadvantageous in CD34 + monocultures, as 
he cells are in need of the necessary stimulation to differentiate 
owards desired cell lineages. On the other hand, Mortera-Blanco 
t al. indicated that a well compartmentalized 3D culturing envi- 
onment, based on PLGA or PU scaffolds, may serve as an impor- 
ant counterbalance to cytokine stimulation during hematopoiesis 
128] . On this basis, the next major step towards applicable in vitro 
ifferentiation procedures would be to design a regenerating cell 
ulture system that can maintain human CD34 + HSPC stemness 
hile promoting efficient hematopoietic differentiation as demon- 
trated by Severn et al. in 2016 10 and 2019 11 [ 127 , 217 ]. These stud- 
es clearly show that the use of scaffolds as BM surrogates such as 
ollagen I-coated PU [ 128 , 217 ] and scaffolds prepared by polymer- 
zed high internal phase emulsions [127] work well as sustainable 
ulturing models. They provide a fully defined cellular and chem- 
cal composition facilitating the maintenance of an initial CD34 + 
ell population inside the scaffolds over 28 days, while releasing 
he progenitor cells that can be further differentiated. 
Platelets and erythrocytes need specific micro niches within 
he BM for their maturation. Tight cell contacts are necessary to 
ransmit intercellular stimulatory signals [218] providing opportu- 
ities to enhance current differentiation models. This was recently 
emonstrated by the formation of erythroid progenitors in 3D cell 
ggregates [219] , which are able to imitate the observed in vivo 
ell proximity within erythroblastic islands and support the termi- 
al enucleation of human UCB-derived CD34 + HSPC-derived RBCs. 
n 2019, Allenby et al. provided evidence that a combinational 
pproach to address current challenges of in vitro differentiation, 
amely low yield, unphysiologically high cytokine concentrations 
nd exhaustion of stem cell pools while maintaining high cell den- 
ities, is possible. Using a 3D hollow fiber reactor, consisting of four 
ermeable ceramic hollow fibers surrounded by a collagen coated 
U scaffold, they reported the evolution of dynamic hematopoi- 
tic microenvironments and a reconstruction of the vascular sys- 
em and the HSC niche in BM only with SCF and erythropoietin 
upplementation [220] . 
T-cells mature in the thymus under the control of Notch 
eceptor-DLL and HLA-T-cell receptor signaling, provided by cell- 
ell contacts with stromal thymic cells [221] . Therefore, early ap- 
roaches on T-cell generation were contingent on DLL expressing 
eeder cells [222–224] . One of the first steps towards stromal-free 
n vitro differentiation was provided by the successful differentia- 
ion of human CD34 + CD38 −/low HSPCs on Fc-DLL-1-coated plates 
sing surface immobilized Notch ligands [225] . However, these ap- 
proaches lack clinical applicability as completely xeno-free cultur- 
ing conditions are required. Kratzer et al. developed a nanostruc- 
tured bifunctional PEG-DA hydrogel functionalized with RGD and 
DLL-1 [226] , thereby providing a completely xeno-free culturing 
system. However, in comparison to thymus, the relative simplic- 
ity of the system only allowed for an unnatural T-cell differentia- 
tion of human UCB-derived HSPCs. The use of ICC scaffolds with 
a highly geometrical platform and adaptable features, such as pore 
interconnectivity, size and density, has already provided promis- 
ing results in supporting both B- and T-cell differentiation in vitro 
[ 136 , 137 , 227 ]. Lee et al. used a layer-by-layer molecular assembly
technique to immobilize DLL-1 Notch ligands on the ICC surface to 
differentiate human BM-derived CD4 + depleted CD34 + HSPCs into 
CD8 −/CD4 + T-cells [136] . 
Considering the varying composition of specific stromal cells in 
HSC subniches in the BM and the resulting variance in extracellular 
signals maturing HSCs are exposed to [228] , the reconstitution of 
a biologically reliable imitation for HSC differentiation studies still 
remains a challenging task. 
9. Biomaterials for studying the pathophysiology of HSC niches 
Both infectious and malignant diseases can affect BM. While 
there are only a few biomaterial-based models for infectious BM 
pathologies [120] , most research in this field focusses on malignant 
diseases. In the subsequent chapters, we will discuss the current 
scenario and future prospects of ongoing research in biomaterial- 
based in vitro studies investigating malignant diseases affecting the 
HSC niche in the BM. 
9.1. Acute myeloid leukemia 
Acute myeloid/myelogenous leukemia (AML) is a malignancy of 
the hematopoietic system characterized by the accumulation of ab- 
normal blasts in the BM and impairment of normal hematopoiesis 
[229] . Even if remission rates for newly diagnosed patients are ac- 
ceptable [230] , high relapse rates [231] constitute a major hurdle 
in the treatment of this disease, which is associated with a low 
5-year survival rate [232] . This reflects the inadequacy of currently 
available options for clinical management of AML, underscoring the 
need for novel alternatives. An ideal solution would be to design a 
platform for drug testing that captures enough complexity of the 
BM, so it has predictive power while being tractable, and does not 
rely on animal models. Leukemic cells are known to reconfigure 
their environment, modifying the healthy HSC niche to one that is 
amicable to their own survival [233] . This niche is where leukemic 
stem cells are thought to reside. These cells can remain in a quies- 
cent state which makes them resistant to chemotherapy, contribut- 
ing to relapse after treatment [234] . 
An early effort [235] explored several FDA-approved materials 
to create highly porous scaffolds. PLGA , PU, PMMA , PDLLA , PCL and 
polystyrene foams were obtained using thermally-induced phase 
separation (TIPS) with pore sizes ranging from 100 to 250 μm. 
These polymers showed a varying degree of success in maintain- 
ing long-term (2 months) viability of several leukemia cell lines, 
with PU and PLGA performing best. Coating of the scaffolds with 
ECM proteins (FN or collagen I) significantly improved cell growth. 
Nair et al. successfully cultured AML cell lines on 3D structures 
made of a PU/PLLA composite in a range of proportions of the two 
components [14] . This material was subjected to TIPS to obtain a 10 Results were affirmed by flow cytometry (CD34, CD36, CD14, CD235a, CD61 and 
D233) and immunofluorescence stainings (IgG1, CD44, CD34, CD235a, CD42b, Cal- 
rotectin). 
11 Results were affirmed by flow cytometry (CD34, CD36, CD14, CD235a, CD61) 








ulture platform with a micro- and nanostructure reminiscent of 
 decellularized BM and subsequently coated with FN. Markedly 
igher resistance of the cells to anti-neoplastic drugs was observed 
ompared to TCP and FN-coated 2D cell culture devices, underscor- 
ng the key effect of dimensionality. A recent work by Karimpoor 
t al. [236] used a microfluidic bubbling technique to produce an 
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lginate foam to which HAp nanoparticles were added to study 
hemotherapy sensitivity of primary AML cells. When cultured in 
hese alginate foams, AML cells showed a significant decrease in 
heir sensitivity to doxorubicin. 
While the results of AML cell monoculture in 3D platforms 
re enlightening, other cell types can influence the behavior of 
eukemic cells. Aljitawi et al. [237] demonstrated that co-culture 
f leukemia cells and MSCs in PLGA scaffolds was feasible. They 
howed a general trend of increased resistance of AML cell lines to 
oxorubicin when co-cultured with MSCs in a 3D culture device. 
SCs are not the only cells involved in sustaining the leukemic 
iche. ECs are known to play a relevant role in AML cell sur- 
ival [238] and the maintenance of residual disease [239] . Several 
iomaterials have been used to explore the interaction between 
eukemic cells and ECs. A starPEG-heparin hydrogel, functionalized 
ith the integrin-binding RGD peptide containing an MMP degrad- 
ble crosslinker, was used to establish a tri-culture of AML cells 
either primary or cell lines), MSCs and ECs. Drug response studies 
howed increased AML cell resistance to daunorubicin and cytara- 
ine in tri-culture versus monoculture, both in 2D and 3D. Combi- 
ation of these drugs resulted in total, or near total, disruption of 
he cultures [240] . 
.2. Multiple myeloma 
Multiple myeloma (MM), the second most common hematolog- 
cal cancer, is a neoplasia that derives from the proliferation of ma- 
ignant plasma cells [229] . As in AML, traditional cell culture obvi- 
tes the role of the microenvironment, which can lead to contra- 
ictory results [ 241 , 242 ]. 
To better study MM in its niche, Kirshner et al. [243] used Ma- 
rigel ® for in vitro 3D studies of MM samples. This system, which 
ncluded cells from the stroma, was used to study both MM and 
tromal cell response in vitro to melphalan and bortezomib. De- 
pite the significant results reported in this work, the use of Ma- 
rigel ® is not considered ideal given its batch-to-batch variability 
nd incompletely defined composition [244] ; more defined alter- 
atives are preferred. Calimeri et al. [245] used porous PCL scaf- 
olds as an alternative to the human fetal bone chips needed in the 
CID-hu mouse model of MM [229] . Seeding of the scaffolds with 
nsorted BM-derived MNCs from MM patients and implantation 
nto mice achieved in vivo expansion of MM cells on a synthetic 
latform. A 3D culture platform that does not depend on animals 
as reported by La Puente et al. [246] . They used a crosslinked 
lasma fibrinogen scaffold and BM cells (stromal cells, ECs and 
M cells), both components derived from MM patients, to estab- 
ish a 3D culture with drug and oxygen gradients in which MM 
ells showed increased resistance to antineoplastic drugs. Building 
p on this platform, they were also able to show a recapitulation 
f patient-specific response to the treatment [247] . Reagan et al. 
sed porous silk scaffolds to establish 3D cultures of MSCs and 
n MM cell line. The former were induced to deposit mineral on 
he material to better mimic the structure of the BM, so the MM 
ells got physiologically relevant environmental cues. As with the 
ther works cited, they found an increased resistance of MM cells 
o bortezomib in 3D co-cultures [15] . 
.3. Bone metastatic carcinomas 
Breast, prostate and renal carcinomas commonly metastasize to 
he bone and result in very poor prognosis and high fatality rate 
248] . In 1889, Dr. Stephan Paget shed some light on this phe- 
omenon with his “seed and soil” theory, suggesting that the inci- 
ence of metastasis in certain organs is not by chance [249] . The 
resence of dense vascular networks, different cells and a rich mi- 
ieu of soluble factors makes the BM a preferable “soil” for tu- 
mor cells or the “seeds”. [250] . Several studies have drawn par- 
allels between the homing of HSCs and tumor cell migration to 
the BM [251] . Signals from the primary tumor sites recruit sup- 
portive stromal components in the BM and lay the groundwork 
for tumor cell arrival, establishing the so-called “pre-metastatic 
niches”. Furthermore, it has been observed that these cells com- 
pete with the HSCs to occupy their niches, thereby giving rise 
to the concept of “hijacked niches” [250] . Thus, it makes sense 
to mimic the potential permissive niches for understanding the 
mechanisms of tumor progression in bone metastasis. Allocca and 
colleagues observed that human BCCs preferentially migrated to 
the OB- and microvasculature-rich regions in a mouse model. 
A rise in the number of BCCs homing to the bone after HSPC 
mobilization predicated a niche overlap [252] . Similarly, human 
prostate cancer cell lines directly competed with HSPCs to oc- 
cupy murine HSC niches and utilized the CXCL12/CXCR4 path- 
way to gain access and egress from the HSC niche area [253] . 
Often it has been seen that tumor cells acquire stem cell char- 
acteristics, mainly self-renewal and quiescence, resulting in overt 
metastasis and chemoresistance, respectively [250] . Shiozawa et al. 
used a mouse model to show that prostate cancer cells migrat- 
ing to the BM, specifically to the osteoblastic niche, acquired stem 
cell characteristics [254] . Cancer cells are also mechanosensitive 
[255] hence it is very likely that they take over the mechanotrans- 
duction pathways of the stem cells. Considering all scenarios, it 
is quite important to investigate the events occurring in the BM 
HSC niche post tumor cell arrival. Starting with simple hydro- 
gels to more complex systems involving microfluidics (reviewed in 
[256] ), on-chip devices (reviewed in [ 257 , 258 ]) or bioprinted scaf- 
folds, biomaterials have indeed progressed the study of metasta- 
sis to a great extent. The lion ́s share of in vitro biomaterial-based 
studies focusing on tumor-stromal-endothelial interactions in BM 
have used MSCs, OBs, ECs or fibroblasts, which have clarified many 
mechanisms, opened up new therapeutic possibilities and paved 
the way for further research. For example, Bray et al. designed an 
advanced biphasic in vitro microenvironment that mimicked breast 
tumor tissue (MCF-7 and MDA-MB-231 in a hydrogel) spatially 
separated with a mineralized bone construct (human primary OBs 
in a cryogel). 3D printed nanocomposite matrices have served as 
a tool to study BCC-MSC [259] and BCC-OB [260] interactions. A 
3D microfluidic model developed by Bersini et al. recreated a vas- 
cularized bone microenvironment with a tri-culture of MDA-MB- 
231 cells, osteogenically differentiated human BM-derived MSCs 
and HUVECs. They observed that MSC-conditioned medium pro- 
moted extravasation and bone-secreted CXCL5 and BCC-secreted 
CXCR2 played important roles in the process [261] . Microfluidic de- 
vices have also enabled investigations about circulating tumor cell 
tropism to distant secondary organs [262] , extravasation [263] and 
mechanoregulation [264] . In 2018, Marturano-Kruik et al. devel- 
oped a perfused bone perivascular niche-on-a-chip to investigate 
the progression and drug resistance of BCCs colonizing the bone. It 
included a functional human tri-culture using MSCs, ECs and MDA- 
MB-231 cells with stable vascular networks within a 3D native 
bone matrix cultured on a microfluidic chip. The incorporation of 
controlled flow velocities, shear stresses and oxygen gradients led 
to long-lasting, self-assembled vascular networks without the need 
to supplement with angiogenic factors. The authors observed that 
the MDA-MB-231 cells, exposed to interstitial flow within the sys- 
tem, persist in a slow-proliferative state associated with increased 
drug resistance. They concluded that interstitial flow promoted the 
formation of stable vasculature and mediated cancer cell coloniza- 
tion [155] . 
Progress in tissue engineering has prompted the integration of 
bone scaffolds into animal models in numerous studies with very 
promising results. One of the first experiments was performed in 
2007, when Moreau et al. successfully incorporated a cell-laden silk 12 
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caffold in mice and studied the combined effect of BMP-2 and 
M-derived MSCs in breast cancer bone metastasis [265] . An inter- 
sting study from 2018 used collagen I-coated ICC hydrogel scaf- 
olds, incorporated with stromal cells to design a “pre-metastatic 
iche”. A vascular niche was formed post implantation, which re- 
ruited circulating tumor cells, released from a human prostate tu- 
or xenograft [266] . As is evident from the discussed references 
he majority of experiments conducted to explore the effects of 
etastasis on HSPCs and vice versa, are in vivo studies. Indeed, 
iomaterial-based xenografts have the potential to mimic the com- 
lexity of the niche and can be considered a powerful approach. 
owever, owing to the dissimilarities between murine and human 
ematopoietic systems, the capability of these models to capture 
he long-term evolution of the metastatic niche and their rele- 
ance to humans remains a good question. In vitro studies incor- 
orating primary human HSPCs and metastatic cancer cells along 
ith other niche components utilizing a biomaterial platform are 
uite underrepresented. The fact that there is an immediate need 
or biomaterial-based in vitro models of various metastatic niches, 
hich delve deeper into the human HSC and metastatic cancer cell 
nteractions, demands the attention of researchers. 
0. Future prospects 
Looking back at the last 20 years of research on HSC niches, 
ast progress was made by assessing them and their biology in an- 
mal models – mostly mice. In these settings, the influence of indi- 
idual factors was studied in “top-down” approaches by looking at 
he entire functional system in the animal and eradicating, influ- 
ncing or adding particular factors and studying the effect of these 
lterations on the hematopoietic system. Attempts to recapitulate 
he HSC niche in vitro have mainly been guided by the perspec- 
ive of producing hematopoietic cells for cellular therapies or test- 
ng drugs in biomimetic systems. However, these systems can also 
e used in fundamental research with “bottom-up” creation of ar- 
ificial HSC niches. These simplified artificial niches allow to add 
ne factor after another or to modulate parameters independently 
nd thus, to study the influence of each individually added factor 
n the HSC niche – a “bottom-up” approach of research synergisti- 
ally supplementing the “top-down” approaches in animal studies. 
iomaterials play an important role in the designing of artificial 
SC niches and the rapid progress in this field allows engineering 
ore and more complex systems. In this way, artificial niches will 
ecome a valuable tool for elucidation of the HSC niche as well 
s for clinical and pharmaceutical applications. This includes not 
nly the biology and biochemistry of the HSC niche but also its 
iophysics. The importance of biophysics in the HSC niche is be- 
oming increasingly clear; however, many studies are phenomeno- 
ogical. The molecular pathways underlying the sensitivity of HSCs 
o biophysical parameters such as matrix stiffness or surface pat- 
erning is yet to be discovered. These studies will be enabled by 
iomaterials that allow tuning individual parameters such as sur- 
ace patterning, matrix stiffness, shear forces or porosity precisely 
nd independently. 
Advances in the fields of biomaterials, biochemistry and cell bi- 
logy create more and more complex artificial HSC niches that get 
loser and closer to their natural archetype. As biomaterials are the 
ocus of this review, on-chip-devices and bioprinting need men- 
ioning as examples for such advances. BM-on-chips have already 
een established. They allow integrating artificial HSC niches with 
icrofluidics. Furthermore, on-chip-devices open the avenue to in- 
estigate BM- and HSC niches-on-chips in combination with other 
rgans-on-chips and are promising for drug screening purposes. 
his also applies when pathophysiological processes affecting mul- 
iple organs such as bone metastasis are mimicked. Bioprinting al- 
ows combining different types of cells and materials within one 
printed model to an extent, which is difficult to achieve with clas- 
sical biomaterial synthesis routes. This is particularly important for 
BM analogs, in which a multitude of different cell types along with 
materials mimicking soft marrow and stiff bone tissue need to be 
added and precisely positioned for a full biomimicry. Combining 
bioprinting with on-chip-devices will greatly enhance the possible 
complexity that can be used to rebuild the HSC niche in vitro . 
Mimicking pathophysiological conditions of the BM with the 
help of biomaterials is an emerging field of research. Often, ma- 
terials for 3D culture or mimicking healthy BM are applied and 
brought to a diseased phenotype by applying disease-derived pri- 
mary cells or cell lines. However, in many diseases not only the 
cells but also their environment and its material properties are 
changed. Biomaterials will allow to mimic also these diseased 
environments and thus bring disease models to a new level of 
biomimicry. Fabrication of 3D systems incorporating multiple cell 
types which facilitate differentiation of HSCs to mature blood cells 
is another application that will largely benefit from such complex 
biomimetics. 
Overall, biomaterials have brought new aspects into research on 
HSCs and their possible applications. The potential of combining 
tailor-made biomaterials with HSC research is not fully unlocked 
yet. Novel developments in the field of biomaterials will further 
enhance the chances of this interdisciplinary approach for funda- 
mental research on HSCs and their applications. 
11. Summary and conclusions 
Biomaterials have paved the way for unraveling the importance 
of cell-material interactions in attempts to control stem cell behav- 
ior in vitro, both for fundamental research as well as applications 
including cellular therapies or drug-testing platforms. HSCs present 
a specific case in comparison to other stem cells. This is because 
their niches in the BM, on which they depend, are highly complex 
and intricate microenvironments, and hence are difficult to mimic 
in vitro . 
2D biomaterial systems allow to dissect the niche complexity 
into particular parameters and factors and to investigate their in- 
fluence on HSCs independently. These studies led to the identifi- 
cation of crucial ECM proteins and cellular ligands for in vitro HSC 
culture and to the observation that they are not only sensitive to 
the biochemical but also to the physical properties of their envi- 
ronment such as stiffness or ligand nanopatterning and topogra- 
phy. 3D biomaterial systems allowed a closer mimicry of the nat- 
ural scenario. Hydrogels and inorganic bone-mimicking scaffolds 
are generally used and have shown that the 3D architecture, direct 
and indirect communication of cells, diffusion of soluble molecules 
and their availability within the 3D structures play important roles. 
Co-cultures of HSPCs with niche cells proved to be efficient in 
realizing important niche characteristics in vitro , namely allowing 
for balanced HSC maintenance (to some degree) and differentia- 
tion. While maintaining HSCs in vitro is the fundamental basis for 
applications aiming at HSC multiplication for transplantation, tar- 
geted differentiation in an artificial environment is the basis for 
in vitro blood production. Therefore, biomaterial-based approaches 
gain importance in studies regarding in vitro production of mature 
blood cells. 
The tight balance of the niche gets disturbed in malignant dis- 
eases of the hematopoietic system or bone metastasis. In vitro 
models of such diseases enable fundamental studies on the steps 
in disease progression that are difficult to assess in human pa- 
tients or regarding processes that differ between human beings 
and animal models. Furthermore, biomaterial-based approaches al- 
low the preparation of drug-testing platforms for different diseases 
and patient-specific models for individualized medicine. While sev- 
eral studies show the principal applicability of HSC niche or BM 13 
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odels for drug testing, the transfer to industrial or clinical set- 
ings is yet to be established. 
The emergence of technologies like bioprinting and on-chip de- 
ices have empowered the development and study of more and 
ore complex in vitro models of the HSC niche. Furthermore, 
timuli-responsive and degradable materials are ready to include 
ime-dependent properties such as matrix stiffening, degradation 
r growth factor release into niche models. The more complex the 
esigned systems, the closer they get to the natural niche. How- 
ver, increasing complexity can also hinder concise experiments 
r the transfer of techniques into application. Therefore, the used 
ystem has to be carefully chosen according to the scientific ques- 
ion to be addressed, the needs of the respective experiment, or 
he particular application. For example, for research on the influ- 
nce of individual biophysical parameters on HSCs, 2D biomate- 
ial substrates that allow to tune these parameters independently 
rom others, might be better suited than a complex 3D co-culture 
ystem. For applications aiming to mimic natural processes of the 
iche, the complexity of the niche has to be reduced to the es- 
entials for this specific process concerning different types of cells, 
CM molecules, soluble factors, 3D architecture and arrangement 
f the constituents. In this way, simplified artificial HSC niches can 
e created that are as complex as necessary for the particular pur- 
ose and at the same time as simple as possible. 
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